Variant report
Variant | rs12102776 |
---|---|
Chromosome Location | chr16:31166028-31166029 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | RAD21 | chr16:31165782-31166063 | Hela-S3 | cervix: | n/a | n/a |
2 | TCF7L2 | chr16:31165797-31166270 | Hela-S3 | cervix: | n/a | n/a |
3 | CEBPB | chr16:31165758-31166175 | Hela-S3 | cervix: | n/a | n/a |
4 | BRCA1 | chr16:31165804-31166090 | Hela-S3 | cervix: | n/a | n/a |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:31165273..31167495-chr16:31190173..31191698,2 | K562 | blood: | |
2 | chr16:31163570..31167428-chr16:31190002..31192096,4 | MCF-7 | breast: | |
3 | chr16:31153578..31155721-chr16:31165072..31166722,2 | MCF-7 | breast: | |
4 | chr16:31164437..31166721-chr16:31189439..31192571,4 | MCF-7 | breast: | |
5 | chr16:31165839..31168639-chr16:31188061..31189958,2 | K562 | blood: | |
6 | chr16:31157987..31161829-chr16:31166001..31169725,4 | K562 | blood: | |
7 | chr16:31155383..31157939-chr16:31165219..31167593,2 | K562 | blood: | |
8 | chr16:31163863..31166773-chr16:31190173..31192747,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PRSS36 | TF binding region |
ENSG00000178226 | Chromatin interaction |
ENSG00000089280 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1060506 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs10871454 | 0.92[CHD][hapmap] |
rs11150604 | 0.92[CHD][hapmap] |
rs11862744 | 0.92[CHD][hapmap] |
rs11865038 | 0.82[CHB][hapmap] |
rs11865499 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs12597511 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs14235 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs1549293 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs1978487 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs2032915 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs2303222 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs2359612 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs2855475 | 0.82[CHB][hapmap] |
rs35468353 | 0.92[CHD][hapmap] |
rs3751855 | 0.82[CHB][hapmap] |
rs4468641 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs4527034 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs4889623 | 1.00[CHB][hapmap];0.87[GIH][hapmap];0.91[JPT][hapmap];0.86[MEX][hapmap] |
rs4889625 | 0.89[AMR][1000 genomes];0.99[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs57611503 | 0.87[ASN][1000 genomes] |
rs6565217 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs7190802 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.91[GIH][hapmap];0.91[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.88[AMR][1000 genomes];0.99[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs7196726 | 0.82[CHB][hapmap] |
rs7197717 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs7199949 | 0.82[CHB][hapmap] |
rs7294 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs732172 | 0.92[CHD][hapmap] |
rs749670 | 0.82[CHB][hapmap] |
rs749671 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs749767 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs750952 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs8050894 | 0.82[CHB][hapmap] |
rs881929 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs889548 | 0.82[CHB][hapmap] |
rs889555 | 0.84[CHD][hapmap] |
rs9923231 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs9934438 | 0.82[CHB][hapmap];0.91[CHD][hapmap] |
rs9936329 | 0.82[CHB][hapmap];0.92[CHD][hapmap] |
rs9939286 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs9939417 | 0.92[CHD][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1062456 | chr16:30442166-31253997 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 437 gene(s) | inside rSNPs | diseases |
2 | nsv542898 | chr16:30442166-31253997 | Enhancers Active TSS Strong transcription Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 437 gene(s) | inside rSNPs | diseases |
3 | nsv905729 | chr16:30642867-31247924 | Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 387 gene(s) | inside rSNPs | diseases |
4 | nsv431451 | chr16:30682399-31340999 | Transcr. at gene 5' and 3' Genic enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 350 gene(s) | inside rSNPs | diseases |
5 | nsv905734 | chr16:30877544-31191482 | Active TSS Strong transcription Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 271 gene(s) | inside rSNPs | diseases |
6 | nsv905735 | chr16:30890538-31247924 | Strong transcription Genic enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 264 gene(s) | inside rSNPs | diseases |
7 | nsv457483 | chr16:30903679-31191482 | Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers Strong transcription Enhancers ZNF genes & repeats Weak transcription Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 253 gene(s) | inside rSNPs | diseases |
8 | nsv571820 | chr16:30903679-31191482 | Enhancers Genic enhancers Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 253 gene(s) | inside rSNPs | diseases |
9 | esv1797877 | chr16:30948643-31188432 | Flanking Active TSS Enhancers Weak transcription Strong transcription Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 114 gene(s) | inside rSNPs | diseases |
10 | nsv905740 | chr16:31066249-31232437 | Flanking Active TSS Enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Active TSS Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 202 gene(s) | inside rSNPs | diseases |
11 | nsv905741 | chr16:31066249-31247924 | Genic enhancers Weak transcription Flanking Active TSS Active TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 202 gene(s) | inside rSNPs | diseases |
12 | nsv905742 | chr16:31102321-31247924 | Weak transcription Active TSS Strong transcription Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 188 gene(s) | inside rSNPs | diseases |
13 | nsv542900 | chr16:31137352-31197027 | Enhancers Genic enhancers Active TSS Flanking Active TSS Strong transcription Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 165 gene(s) | inside rSNPs | diseases |
14 | esv987713 | chr16:31163107-31173998 | Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 6 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs12102776 | ITGAX | cis | multi-tissue | Pritchard |
rs12102776 | MYST1 | cis | cerebellum | SCAN |
rs12102776 | FUS | cis | cerebellum | SCAN |
rs12102776 | YPEL3 | cis | parietal | SCAN |
rs12102776 | MYST1 | cis | parietal | SCAN |
rs12102776 | MYST1 | Cis_1M | lymphoblastoid | RTeQTL |
rs12102776 | C16orf93 | cis | cerebellum | SCAN |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:31154400-31190400 | Weak transcription | Right Atrium | heart |
2 | chr16:31162000-31171200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr16:31163000-31168200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr16:31163000-31168200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr16:31163000-31168600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr16:31163400-31168200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
7 | chr16:31163800-31168400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
8 | chr16:31163800-31168400 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
9 | chr16:31166000-31168800 | Weak transcription | Hela-S3 | cervix |